CSL (ASX: CSL) reaffirms guidance, expects 13-17% YoY rise in FY24 NPATA
CSL Limited (ASX: CSL) is an ASX-listed biotechnology firm which is involved in research, development, marketing, manufacturing and distribution of biopharmaceutical products and services. The company provides innovative life-saving medicines in over 100 countries. In the first half of the financial year 2024 (1HFY24), …
Team Kalkine |
07 Mar 2024| Read Time : 10 Mins